Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study - PubMed (original) (raw)
Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study
Naomi M Hamburg et al. Circulation. 2008.
Abstract
Background: Digital pulse amplitude augmentation in response to hyperemia is a novel measure of peripheral vasodilator function that depends partially on endothelium-derived nitric oxide. Baseline digital pulse amplitude reflects local peripheral arterial tone. The relation of digital pulse amplitude and digital hyperemic response to cardiovascular risk factors in the community is unknown.
Methods and results: Using a fingertip peripheral arterial tonometry (PAT) device, we measured digital pulse amplitude in Framingham Third Generation Cohort participants (n=1957; mean age, 40+/-9 years; 49% women) at baseline and in 30-second intervals for 4 minutes during reactive hyperemia induced by 5-minute forearm cuff occlusion. To evaluate the vascular response in relation to baseline, adjusting for systemic effects and skewed data, we expressed the hyperemic response (called the PAT ratio) as the natural logarithm of the ratio of postdeflation to baseline pulse amplitude in the hyperemic finger divided by the same ratio in the contralateral finger that served as control. The relation of the PAT ratio to cardiovascular risk factors was strongest in the 90- to 120-second postdeflation interval (overall model R(2)=0.159). In stepwise multivariable linear regression models, male sex, body mass index, ratio of total to high-density lipoprotein cholesterol, diabetes mellitus, smoking, and lipid-lowering treatment were inversely related to PAT ratio, whereas increasing age was positively related to PAT ratio (all P<0.01).
Conclusions: Reactive hyperemia produced a time-dependent increase in fingertip pulse amplitude. Digital vasodilator function is related to multiple traditional and metabolic cardiovascular risk factors. Our findings support further investigations to define the clinical utility and predictive value of digital pulse amplitude.
Figures
Figure 1
Panel A displays the pulse amplitude tracing in a participant with a PAT ratio in the highest tertile. Panel B displays the pulse amplitude tracing in a participant with a PAT ratio in the lowest tertile. As shown, in the arm undergoing hyperemia (upper tracing in A and B) baseline amplitude is recorded; subsequently during cuff inflation flow is occluded and rapidly rises after release during the hyperemic period in an individual with a high response (panel A), but in an individual with a low response (panel B). In the contralateral, control finger (lower tracing in A and B) flow continues throughout and there is minimal change in pulse amplitude.
Figure 2
Pulse amplitude response shown for the hyperemic finger and contralateral finger in women and men. Men had lower responses throughout in both fingers. Values are means. The minimum and maximum standard errors were 0.01 to 0.04.
Figure 3
Multivariable relation between cardiovascular risk factors including age, sex, systolic blood pressure, diastolic blood pressure, heart rate, body mass index, total/HDL cholesterol, triglycerides, glucose, diabetes, current smoking, hormone replacement therapy, hypertension treatment, lipid-lowering treatment, and prevalent cardiovascular disease, and the digital hyperemic response (PAT ratio) in the 30 second time intervals after cuff occlusion. As displayed, the strongest relation occurs in the 90-120 second post-deflation interval.
Figure 4
Boxplot of age-adjusted baseline and hyperemic pulse amplitude according to body mass index category and sex (Normal, <25 kg/m2; Overweight, 25 to <30 kg/m2; Obese ≥30 kg/m2). For men n=283, 471, 249 and for women n=501, 253, 200 for normal, overweight and obese, respectively, P for trend <0.0001.
Comment in
- Reliable endothelial function testing: at our fingertips?
Celermajer DS. Celermajer DS. Circulation. 2008 May 13;117(19):2428-30. doi: 10.1161/CIRCULATIONAHA.108.775155. Circulation. 2008. PMID: 18474821 Review. No abstract available.
Similar articles
- Digital Peripheral Arterial Tonometry and Cardiovascular Disease Events: The Framingham Heart Study.
Cooper LL, Wang N, Beiser AS, Romero JR, Aparicio HJ, Lioutas VA, Benjamin EJ, Larson MG, Vasan RS, Mitchell GF, Seshadri S, Hamburg NM. Cooper LL, et al. Stroke. 2021 Aug;52(9):2866-2873. doi: 10.1161/STROKEAHA.120.031102. Epub 2021 Jul 1. Stroke. 2021. PMID: 34192894 Free PMC article. - The relation of digital vascular function to cardiovascular risk factors in African-Americans using digital tonometry: the Jackson Heart Study.
McClendon EE, Musani SK, Samdarshi TE, Khaire S, Stokes D, Hamburg NM, Sheffy K, Mitchell GF, Taylor HR, Benjamin EJ, Fox ER. McClendon EE, et al. J Am Soc Hypertens. 2017 Jun;11(6):325-333.e2. doi: 10.1016/j.jash.2017.04.008. Epub 2017 May 4. J Am Soc Hypertens. 2017. PMID: 28645730 - Association of digital vascular function with cardiovascular risk factors: a population study.
Kuznetsova T, Van Vlierberghe E, Knez J, Szczesny G, Thijs L, Jozeau D, Balestra C, D'hooge J, Staessen JA. Kuznetsova T, et al. BMJ Open. 2014 Mar 24;4(3):e004399. doi: 10.1136/bmjopen-2013-004399. BMJ Open. 2014. PMID: 24662447 Free PMC article. - Relations of Metabolically Healthy and Unhealthy Obesity to Digital Vascular Function in Three Community-Based Cohorts: A Meta-Analysis.
Brant LC, Wang N, Ojeda FM, LaValley M, Barreto SM, Benjamin EJ, Mitchell GF, Vasan RS, Palmisano JN, Münzel T, Blankenberg S, Wild PS, Zeller T, Ribeiro AL, Schnabel RB, Hamburg NM. Brant LC, et al. J Am Heart Assoc. 2017 Mar 8;6(3):e004199. doi: 10.1161/JAHA.116.004199. J Am Heart Assoc. 2017. PMID: 28275071 Free PMC article. Review. - Assessment of endothelial function using digital pulse amplitude tonometry.
Hamburg NM, Benjamin EJ. Hamburg NM, et al. Trends Cardiovasc Med. 2009 Jan;19(1):6-11. doi: 10.1016/j.tcm.2009.03.001. Trends Cardiovasc Med. 2009. PMID: 19467447 Free PMC article. Review.
Cited by
- Non-invasive peripheral vascular function, incident cardiovascular disease, and mortality in the general population.
Schnabel RB, Magnussen C, Schulz A, Ojeda FM, Schmitt VH, Arnold N, Sinning CR, Beutel ME, Schmidtmann I, Pfeiffer N, Leuschner A, Lackner KJ, Gori T, Benjamin EJ, Binder H, Wild PS, Blankenberg S, Münzel T; Gutenberg Health Study investigators. Schnabel RB, et al. Cardiovasc Res. 2022 Feb 21;118(3):904-912. doi: 10.1093/cvr/cvab087. Cardiovasc Res. 2022. PMID: 33724298 Free PMC article. - Decrease of postprandial endothelial dysfunction by spice mix added to high-fat hamburger meat in men with Type 2 diabetes mellitus.
Li Z, Henning SM, Zhang Y, Rahnama N, Zerlin A, Thames G, Tseng CH, Heber D. Li Z, et al. Diabet Med. 2013 May;30(5):590-5. doi: 10.1111/dme.12120. Epub 2013 Mar 7. Diabet Med. 2013. PMID: 23320544 Free PMC article. Clinical Trial. - Effect of a wild blueberry (Vaccinium angustifolium) drink intervention on markers of oxidative stress, inflammation and endothelial function in humans with cardiovascular risk factors.
Riso P, Klimis-Zacas D, Del Bo' C, Martini D, Campolo J, Vendrame S, Møller P, Loft S, De Maria R, Porrini M. Riso P, et al. Eur J Nutr. 2013 Apr;52(3):949-61. doi: 10.1007/s00394-012-0402-9. Epub 2012 Jun 26. Eur J Nutr. 2013. PMID: 22733001 Clinical Trial. - Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function.
Li J, Flammer AJ, Lennon RJ, Nelson RE, Gulati R, Friedman PA, Thomas RJ, Sandhu NP, Hua Q, Lerman LO, Lerman A. Li J, et al. Mayo Clin Proc. 2012 Oct;87(10):968-75. doi: 10.1016/j.mayocp.2012.07.004. Epub 2012 Sep 12. Mayo Clin Proc. 2012. PMID: 22980166 Free PMC article. - Acute endothelial response to testosterone gel administration in men with severe hypogonadism and its relationship to androgen receptor polymorphism: a pilot study.
Francomano D, Fattorini G, Gianfrilli D, Paoli D, Sgrò P, Radicioni A, Romanelli F, Di Luigi L, Gandini L, Lenzi A, Aversa A. Francomano D, et al. J Endocrinol Invest. 2016 Mar;39(3):265-71. doi: 10.1007/s40618-015-0325-4. Epub 2015 Jul 11. J Endocrinol Invest. 2016. PMID: 26162521 Free PMC article. Clinical Trial.
References
- Widlansky ME, Gokce N, Keaney JF, Jr., Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149–1160. - PubMed
- Hamburg NM, Vita JA. Endothelial dysfunction in atherosclerosis: Mechanisms of impaired nitric oxide bioactivity. In: Loscalzo J, editor. Molecular mechanisms of atherosclerosis. Taylor & Francis; London: 2006.
- Gokce N, Keaney JF, Jr., Menzoian JO, Watkins M, Hunter L, Duffy SJ, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function. Circulation. 2002;105:1567–1572. - PubMed
- Kuvin JT, Patel AR, Sliney KA, Pandian GP, Sheffy J, Schnall RP, Karas RH, Udelson JE. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J. 2003;146:168–174. - PubMed
- Kuvin JT, Mammen A, Mooney P, Alsheikh-Ali AA, Karas RH. Assessment of peripheral vascular endothelial function in the ambulatory setting. Vasc Med. 2007;12:13–16. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL 080124/HL/NHLBI NIH HHS/United States
- R01 HL080124-03/HL/NHLBI NIH HHS/United States
- R01 HL080124-01/HL/NHLBI NIH HHS/United States
- R01 HL076784/HL/NHLBI NIH HHS/United States
- HL70100/HL/NHLBI NIH HHS/United States
- K24 HL004334-04/HL/NHLBI NIH HHS/United States
- R01 HL080124-02/HL/NHLBI NIH HHS/United States
- R01 HL076784-05/HL/NHLBI NIH HHS/United States
- N01HC25195/HL/NHLBI NIH HHS/United States
- R01 HL070100/HL/NHLBI NIH HHS/United States
- R01 HL076784-01/HL/NHLBI NIH HHS/United States
- R01 HL070100-03/HL/NHLBI NIH HHS/United States
- R01 AG028321-03/AG/NIA NIH HHS/United States
- R01 AG028321-01/AG/NIA NIH HHS/United States
- R01 AG028321-02/AG/NIA NIH HHS/United States
- R01 HL076784-03/HL/NHLBI NIH HHS/United States
- N01 HC025195/HC/NHLBI NIH HHS/United States
- R01 HL070100-02/HL/NHLBI NIH HHS/United States
- R01 HL070100-04/HL/NHLBI NIH HHS/United States
- R01 HL070100-01/HL/NHLBI NIH HHS/United States
- AG028321/AG/NIA NIH HHS/United States
- R01 HL076784-04/HL/NHLBI NIH HHS/United States
- K24 HL004334/HL/NHLBI NIH HHS/United States
- K12 HL083781/HL/NHLBI NIH HHS/United States
- HL083781/HL/NHLBI NIH HHS/United States
- R01 HL076784-02/HL/NHLBI NIH HHS/United States
- K24 HL004334-05/HL/NHLBI NIH HHS/United States
- HL076784/HL/NHLBI NIH HHS/United States
- K24 HL004334-06/HL/NHLBI NIH HHS/United States
- R01 HL080124/HL/NHLBI NIH HHS/United States
- 2K24 HL 4334/HL/NHLBI NIH HHS/United States
- N01-HC25195/HC/NHLBI NIH HHS/United States
- R01 AG028321/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources